dermatan sulfate has been researched along with Purpura, Thrombocytopenic, Idiopathic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauters, A; Elalamy, I; Ffrench, P; Lasne, D; Tardy, B; Tardy-Poncet, B; Wolf, M | 1 |
| Elliott, WG; Gurbuz, AT; Zia, AA | 1 |
| Bidlingmaier, C; Girisch, M; Kurnik, K; Magnani, HN | 1 |
| Antonijevic, NM; Calija, B; Kovac, M; Mikovic, D; Milosevic, RA; Obradovic, SD; Perunicic, J; Savic, NB; Stanojevic, M; Vasiljevic, Z | 1 |
| Babaev, A; Belway, D; Henley, B; Mesana, T; Rubens, FD | 1 |
1 review(s) available for dermatan sulfate and Purpura, Thrombocytopenic, Idiopathic
| Article | Year |
|---|---|
Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
Topics: Ancrod; Antibodies; Anticoagulants; Arginine; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Practice Guidelines as Topic; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Sulfonamides; Thrombin | 2005 |
4 other study(ies) available for dermatan sulfate and Purpura, Thrombocytopenic, Idiopathic
| Article | Year |
|---|---|
Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases.
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Female; Hemostasis; Heparin; Heparitin Sulfate; Hirudins; Humans; Intensive Care Units; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Retrospective Studies | 2009 |
Safety and efficacy of danaparoid (Orgaran) use in children.
Topics: Adolescent; Adult; Child; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Infant; Infant, Newborn; Male; Purpura, Thrombocytopenic, Idiopathic; Risk Factors; Thrombosis | 2006 |
Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin-induced thrombocytopenia primarily resistant to danaparoid sodium and lepirudin.
Topics: Arthroplasty, Replacement, Hip; Autoantibodies; Chondroitin Sulfates; Dermatan Sulfate; Drug Resistance; Female; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hip Fractures; Hirudins; Humans; Middle Aged; Partial Thromboplastin Time; Plasma; Plasmapheresis; Postoperative Complications; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Salvage Therapy; Thrombophilia; Time Factors | 2006 |
Delayed thrombin generation is not associated with fibrinopeptide formation during prolonged cardiopulmonary bypass with hirudin anticoagulation.
Topics: Adult; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Contraindications; Dermatan Sulfate; Endarterectomy; Fibrinolytic Agents; Fibrinopeptide A; Heparin; Heparitin Sulfate; Hirudins; Humans; Hypertension, Pulmonary; Hypothermia, Induced; Male; Peptide Fragments; Postoperative Complications; Prothrombin; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Thrombectomy; Thrombin; Thrombosis | 2006 |